Community Research and Development Information Service - CORDIS

Results 1 - 10 of 246
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
ID: 115749
Start date: 2015-01-01, End date: 2019-12-31
Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential to improve the development of personalized medicines for cancer patients. This is of particular importance when biopsies of the primary ...
Programme: FP7-JTI
Record Number: 203725
Last updated on: 2017-04-24
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases
ID: 115565
Start date: 2014-02-01, End date: 2019-01-31
We concur to the IMI on “Reclassification of SLE, connective tissue diseases and RA” call by presenting a proposal aimed at using the power of OMICs, and bioinformatics to identify new classifications for diseases known to share common pathophysiological mechanisms. Such know...
Programme: FP7-JTI
Record Number: 203714
Last updated on: 2017-04-24
Combatting Bacterial Resistance in Europe
ID: 115523
Start date: 2013-01-01, End date: 2021-02-28
The emergence of Antibiotic-resistant bacteria (ARB) is a global problem, having recently been elevated to the top three threats identified by the World Health Organisation (WHO), and subject of numerous national and international government activities, including the Trans-At...
Programme: FP7-JTI
Record Number: 203711
Last updated on: 2017-04-24
Solar integrated pressurized high temperature electrolysis
ID: 621173
Start date: 2014-04-01, End date: 2017-06-30
Hydrogen and other fuels are expected to play a key role as energy carrier for the transport sector and as energy buffer for the integration of large amounts of renewable energy into the grid. Therefore the development of carbon lean technologies producing hydrogen at reasona...
Programme: FP7-JTI
Record Number: 185710
Last updated on: 2017-04-17
European Patients' Academy on Therapeutic Innovation
ID: 115334
Start date: 2012-02-01, End date: 2017-01-31
"The proposed project ""European Patients' Academy on Therapeutic Innovation"" (EUPATI) contributes to IMI’s goal of raising patients’ awareness and participation in pharmaceutical R&D. This patient-led academy will provide scientifically reliable, objective, comprehensive in...
Programme: FP7-JTI
Record Number: 203729
Last updated on: 2017-04-17
DIabetes REsearCh on patient sTratification
ID: 115317
Start date: 2012-02-01, End date: 2019-01-31
The overarching aims of the DIRECT consortium, consisting of 20 leading academic groups in diabetes and 5 EFPIA companies, are to identify biomarkers that address current bottlenecks in diabetes drug development and to develop a stratified medicines approach to treatment of t...
Programme: FP7-JTI
Record Number: 203699
Last updated on: 2017-04-17
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk
ID: 115303
Start date: 2012-03-01, End date: 2017-11-30
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia...
Programme: FP7-JTI
Record Number: 203697
Last updated on: 2017-04-17
New Models for Preclinical Evaluation of Drug Efficacy in Common Solid Tumours
ID: 115188
Start date: 2011-02-01, End date: 2016-04-30
Traditional preclinical discovery methods, particularly for target validation, poorly predict drug efficacy, causing a high attrition rate in costly late-stage clinical trials. The PREDECT consortium will focus on complex but transferable, next generation in vitro and in vivo...
Programme: FP7-JTI
Record Number: 203692
Last updated on: 2017-04-17
BeTheCuRE
[PROJECT] BTCURE - BeTheCuRE
ID: 115142
Start date: 2011-04-01, End date: 2017-03-31
BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal models have to develop the line with the different subsets of the human diseases in order to be optimally used for drug discovery and drug ev...
Programme: FP7-JTI
Record Number: 203688
Last updated on: 2017-04-17
European programme in Pharmacovigilance and Pharmacoepidemiology
ID: 115014
Start date: 2009-09-01, End date: 2016-06-30
The Eu2P training network in Pharmacovigilance and Pharmacoepidemiology will meet the needs of industry,regulatory authorities and academia at the European level. It will give access to a harmonised training programme that gathers complementary specialized and eminent Europea...
Programme: FP7-JTI
Record Number: 203686
Last updated on: 2017-04-17
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-04-28
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top